Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
about
Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cellsK-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysisEvidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cellsAmplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNAAnalysis of the genome to personalize therapy for melanomaMutations in the KRAS2 oncogene during progressive stages of human colon carcinomaEmerging concepts in pancreatic cancer medicine: targeting the tumor stromaAnalysis of RAS oncogene mutations in human lymphoid malignanciesPancreatic cancer: pathogenesis, prevention and treatmentCharacterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccinationPotential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancerCharacterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reactionp8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growthImplications of growth factor alterations in the treatment of pancreatic cancerGenetic alterations in pancreatic carcinomaRegular use of aspirin and pancreatic cancer risk.What is the origin of pancreatic adenocarcinoma?Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic CancerLiquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaClinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsFAK and paxillin, two potential targets in pancreatic cancerReactive Oxygen Species and Targeted Therapy for Pancreatic CancerMEK and PI3K inhibition in solid tumors: rationale and evidence to dateMolecular detection of pancreatic neoplasia: Current status and future promiseGenomic alterations in pancreatic cancer and their relevance to therapyGEMMs as preclinical models for testing pancreatic cancer therapiesMultifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literatureClinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic CancerImaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesImpacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancerMouse models of pancreatic cancerPancreatic cancerThe Key Role of Calmodulin in KRAS-Driven AdenocarcinomasThe pancreas cancer microenvironmentHeat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Genetic factors affecting patient responses to pancreatic cancer treatmentThe interplay between obesity and cancer: a fly view
P2860
Q21245757-7FAF4F0B-5826-4FF7-A13A-F1EBD0ECB0DFQ21284688-82BBFF49-73C6-49F7-9575-307FE0CB4A25Q24552563-85354236-FD8C-41EA-B64B-FDCCEF99F4ACQ24568308-4CE4B232-079C-4F2E-B3CF-A81CE1CC0702Q24601008-7697080B-7EAC-4E21-BC0A-C6E1D129143CQ24619532-E1B87744-C6F1-4CB2-9E34-B19FF6098FBDQ24627664-36CA18B8-4253-48B7-A98C-4BC828921338Q24643802-4D6CC26D-3910-40C5-8776-4E767D675700Q24670990-5A3ABF4B-ACB9-4CCB-AB9B-1924B780336CQ24678848-FAE28E1C-E1E1-4E73-9E93-A8DDC393B455Q24685746-EB7B7A91-30A5-4BA9-9B81-77232B3DECA9Q24794417-0D7C05A4-4FD3-4412-81FD-F99E5F47659DQ24797943-B9E8CFA6-7B80-4766-9B08-365FF919FE26Q24800145-D26435E0-825F-4DEF-9105-C3C7A9E96DD0Q24801465-1B2FA3EF-928A-40C3-8E07-8718EE675EDEQ24801805-5B29BD59-ED62-4FDE-92E2-A8AFC99BBA55Q24805751-1CAAF32F-3A70-4BA6-98BD-C28C09B9BACEQ24812935-08591875-EB26-472A-8DFA-20CDC68365CDQ26738873-81E1398E-522B-498C-9D0D-EAF2D32C9A3CQ26739062-7BAD8F92-DA4B-4D38-8094-B90557034E5FQ26744298-6E23D9BD-7522-4A3C-9DDE-6F48E8D861EFQ26744828-17D162A3-DFB9-44AA-BB50-A1E33B8EFF91Q26765360-1FD06E30-DA2C-4AD1-8952-93BA3733EB2FQ26765827-F46EEFBB-8012-496C-BE31-97D75470063EQ26775573-46D6ED0B-9B3B-480A-8785-BEC150BF53BCQ26777379-74809A6D-F21F-4892-8101-EA12141A89B1Q26781443-FC15FEE6-143D-4D0D-ABCC-A041EDA90C9BQ26781848-C80B128A-EB7F-4C09-A3A6-7F06B799E233Q26783424-586F8B0D-F4B7-4277-945E-6DE86B4D27E9Q26785691-841D777F-AA67-4DE8-A57B-4FF729375415Q26828959-B89EF49F-4101-4960-AF99-142393350FA5Q26830681-43E8EACC-93F6-4D78-8176-A48C88984FA7Q26860574-0745BED5-821E-45D4-9338-5063C22FEB4AQ27005724-B99C43CF-EFC5-403D-8A37-BCE24008F80EQ27021883-DD6A4323-C5DD-4102-8D3C-BED921004254Q27026705-E66AD2C1-8488-49CD-AC12-CBED32267E4AQ27851677-2D11E090-A3DF-4FF9-8D3C-FC4BB69F5E0DQ28066454-D42CD302-47B8-43B1-8A4F-0AC8436C13DBQ28075293-6696D9A8-172C-46C5-A7C1-A786CB27D0A0Q28079088-BB1E4462-84ED-4941-8768-EFB2D0CC3EA5
P2860
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@ast
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@en
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@nl
type
label
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@ast
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@en
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@nl
prefLabel
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@ast
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@en
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@nl
P2093
P3181
P1433
P1476
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
@en
P2093
P304
P3181
P356
10.1016/0092-8674(88)90571-5
P407
P577
1988-05-20T00:00:00Z